Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1999 May;43(5):1301–1303. doi: 10.1128/aac.43.5.1301

Resistance to β-Lactam Antibiotics in Pseudomonas aeruginosa Due to Interplay between the MexAB-OprM Efflux Pump and β-Lactamase

Taiji Nakae 1,*, Akira Nakajima 1, Toshihisa Ono 1, Kohjiro Saito 1, Hiroshi Yoneyama 1
PMCID: PMC89266  PMID: 10223959

Abstract

We evaluated the roles of the MexAB-OprM efflux pump and β-lactamase in β-lactam resistance in Pseudomonas aeruginosa by constructing OprM-deficient, OprM basal level, and OprM fully expressed mutants from β-lactamase-negative, -inducible, and -overexpressed strains. We conclude that, with the notable exception of imipenem, the MexAB-OprM pump contributes significantly to β-lactam resistance in both β-lactamase-negative and β-lactamase-inducible strains, while the contribution of the MexAB-OprM efflux system is negligible in strains with overexpressed β-lactamase. Overexpression of the efflux pump alone contributes to the high level of β-lactam resistance in the absence of β-lactamase.


A major problem in Pseudomonas aeruginosa infection is that this organism exhibits natural and acquired resistance to many structurally and functionally diverse antibiotics. The multiple antibiotic resistance of this organism is mainly caused by low outer membrane permeability (11) and the expression of efflux pumps. Three efflux pumps have been documented (4, 5, 8, 14, 15) so far, namely the MexAB-OprM (10, 13), the MexCD-OprJ (12), and the MexEF-OprN (6) pumps. In the wild-type strain only the MexAB-OprM pump is expressed and the others are silent (4, 5, 10, 13). The nalB mutant overexpresses the MexAB-OprM pump (10, 13), rendering the bacterium more resistant than the wild-type strain to certain antibiotics (15). P. aeruginosa also expresses a chromosomally encoded β-lactamase in the presence of an appropriate inducer and shows elevated resistance to β-lactam antibiotics (2, 3). An earlier study predicted a possible interplay between membrane permeability and β-lactamase in β-lactam resistance in P. aeruginosa (7). Thus, it is important to ask which factor contributes most to resistance under various conditions. We addressed this issue by constructing a series of mutants producing different levels of the MexAB-OprM efflux pump and of β-lactamase.

Table 1 lists the strains used, their relevant properties, and β-lactamase activities. The strains PAO1, PAO4096, and TNP001 produce inducible, undetectable, and fully expressed β-lactamase, respectively (2, 17). We mutagenized the oprM gene by inserting a Tetr cassette as reported earlier (18). Manipulation of DNA has been described earlier (16). We confirmed the Tetr marker insertion by amplification of the chromosomal oprM by PCR as described by Ausubel et al. (1) by using the primers 5′-CAGTTGCAGCTGACCAAGG and 5′-TCGCTGGCCTTGACCAGATCG (data not shown). We confirmed by the Western blotting method with an anti-OprM antibody (18) that the mutants carrying the Tetr insertion in oprM showed no detectable OprM protein (data not shown).

TABLE 1.

Bacterial strains, relevant properties, and β-lactamase activitiesa

Strain Parent Relevant property β-Lactamase activity (U)
Reference or study
Uninduced Inducedb
PAO1 Wild type 2.7 × 10−3 0.65 15
TNP024 PAO1 nalB-type derivative 2.8 × 10−3 0.67 This study
TNP025 PAO1 ΔoprM (Tetr insertion) 2.6 × 10−3 0.59 This study
PAO4096 PAO4069 blaP9206 BlaI9407 met9020 pro9024 0.8 × 10−3 0.9 × 10−3 2
TNP026 PAO4096 nalB-type derivative 0.7 × 10−3 NDc This study
TNP027 PAO4096 ΔoprM (Tetr insertion) 0.5 × 10−3 0.6 × 10−3 This study
TNP001 PAO1 β-lactamase fully expressed 2.55 2.03 17
TNP028 TNP001 nalB-type derivative 2.33 2.32 This study
TNP029 TNP001 ΔoprM (Tetr insertion) 2.40 2.82 This study
a

The nalB-type mutants were isolated as previously reported (8). The β-lactamase assay used was also previously reported (17). One unit of β-lactamase hydrolyges 1 μmol of cephalothin per min per mg of protein. 

b

β-Lactamase was induced in the presence of 0.15 μg of imipenem/ml. 

c

ND, not detected. 

We evaluated the role of the efflux pump without β-lactamase by constructing OprM-deficient (ΔOprM), OprM-constitutive (OprM+), and OprM-overexpressed (OprM+++) mutants from a β-lactamase-negative strain (Bla) which produces less than 0.9 × 10−3 U of β-lactamase (Table 1). The β-lactam MICs for the Bla OprM+++ derivative (TNP026) were 8 to 250 times higher than those for the Bla ΔOprM strain (TNP027). These increases in MICs are attributable to the nalB mutation, notably overexpression of the MexAB-OprM pump. This new finding clearly shows that overexpression of the efflux pump alone confers high β-lactam resistance without β-lactamase. The β-lactam MICs for the Bla OprM+ strain (PAO4096) were 2 to 64 times higher than those for the Bla ΔOprM mutant (TNP027) except for meropenem. The higher MICs for PAO4096 than for TNP027 reflect the fraction that the basal level of the MexAB-OprM efflux pump contributes to the intrinsic β-lactam resistance. This result is consistent with recently reported conclusions (9).

Experiments using the strains with fully expressed β-lactamase (Blac OprM+, TNP001), an ΔOprM derivative (TNP029), and an OprM+++ derivative (TNP028) showed entirely different MIC profiles. First of all, the β-lactam MICs for the Blac ΔOprM strain (TNP029) were 64 to 2,000 times higher than those for the Bla ΔOprM mutant (TNP027). This large difference in MICs appears to be due solely to the contribution of the fully expressed β-lactamase (Table 2). The contributions of wild-type and elevated levels of MexAB-OprM expression in the TNP001 strain to the MICs of these β-lactams were nearly masked by high β-lactamase production, since the MICs of these antibiotics for the OprM+++ derivative, TNP028, were only one to four times higher than those for TNP029. Based on these new findings, we conclude that in the β-lactamase fully expressed strain, the β-lactamase predominates in causing β-lactam resistance and the role of the efflux pump is secondary.

TABLE 2.

MICs of antibiotics for strains with different levels of OprM expression and β-lactamase productiona

Strain MIC (μg/ml)
CAZ CZOP CFPM CPR CBPC AZT IPM MPM CPZ CP OFLX
PAO1 0.78 0.78 0.78 1.56 25 3.13 0.78 0.39 3.13 25 0.39
TNP024 3.13 1.56 3.13 3.13 100 12.5 0.78 0.78 12.5 200 1.56
TNP025 0.39 0.2 0.1 0.2 0.39 0.2 0.78 0.1 0.39 1.56 0.05
PAO4096 0.78 0.2 0.39 0.78 12.5 1.56 0.2 0.2 0.78 25 0.2
TNP026 3.13 0.78 1.56 3.13 50 12.5 0.2 0.78 6.25 200 1.56
TNP027 0.39 0.1 0.1 0.1 0.2 0.2 0.2 <0.013 0.2 1.56 0.05
TNP001 50 50 25 50 200 50 0.78 1.56 400 50 0.39
TNP028 50 50 25 50 400 50 0.78 3.13 400 >200 1.56
TNP029 50 25 12.5 50 100 25 0.78 0.78 400 1.56 0.05
a

MICs were determined by the agar dilution method with Mueller-Hinton agar (Becton-Dickinson). Abbreviations: CAZ, ceftazidime; CZOP, cefozopran; CFPM, cefepime; CPR, cefpirome; CBPC, carbenicillin; AZT, aztreonam; IPM, imipenem; MPM, meropenem; CPZ, cefoperazone; CP, chloramphenicol; OFLX, ofloxacin. 

In the next experiment, we designed an experiment taking a wild-type laboratory strain (PAO1) and constructing ΔOprM (TNP025) and nalB (TNP024) mutants. The β-lactamase activities of these strains in the presence and absence of the inducer were 0.59 to 0.67 U and 2.6 × 10−3 to 2.8 × 10−3 U, respectively (Table 1). The β-lactam MICs for the wild-type strain, PAO1, were 0.39 to 25 μg/ml, and these values were unexpectedly only one to four times higher than the MICs of these antibiotics for the Bla counterpart (PAO4096). These results clearly indicate that the contribution of β-lactamase to the MICs of these β-lactams was marginal. This is probably due to poor β-lactamase inducibility of the β-lactams used, since the MICs of these antibiotics for the Blac strain (TNP001) were very high (Table 2).

To determine the role of the efflux pump in β-lactam resistance, we compared the MICs of antibiotics for the Blai OprM+ (PAO1) and the Blai ΔOprM (TNP025) strains. The β-lactams MICs for PAO1 were 2 to 64 times higher than those for TNP025, indicating that the low-level expression of the efflux pump mainly contributes to the intrinsic resistance. This result is consistent with that of a recent report (9). In addition, the MICs of these antibiotics for the Blai OprM+++ strain were 8- to 256-fold higher than those for the Blai ΔOprM strain (TNP025). These results showed that the efflux pump alone can confer very high β-lactam resistance with a negligible contribution of β-lactamase. To ascertain the contribution of inducible β-lactamase to β-lactam resistance in the MexAB-OprM-overexpressed environment, we compared the MICs of β-lactams for TNP024 and TNP026 and found that the MICs for TNP024 were only one to two times higher than those for TNP026, indicating again that the contribution of inducible β-lactamase was small compared with that of the efflux pump under these conditions. After this paper was submitted for publication, Masuda et al. reported on the interplay between β-lactamase and the efflux pump (9). Our results concur in part with theirs and add additional results.

Acknowledgments

This study was supported by grants from the Ministry of Education, the Ministry of Health and Welfare, the Japan Society of Promotion of Science, and the Tokai University School of Medicine.

REFERENCES

  • 1.Ausubel F M, Brent R, Kingston R E, Moore D D, Seidman J G, Smith J A, Struhl K. Current protocols in molecular biology. New York, N.Y: Greene and Wiley Interscience; 1995. [Google Scholar]
  • 2.Bryan L E, Kwan S, Godfrey J A. Resistance of Pseudomonas aeruginosa mutants with altered control of chromosomal β-lactamase to piperacillin, ceftazidime, and cefsulodin. Antimicrob Agents Chemother. 1984;25:382–384. doi: 10.1128/aac.25.3.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Bryan L E. Resistance to antimicrobial agents: the general nature of the problem and the basis of resistance. In: Dogget R G, editor. Pseudomonas aeruginosa. Clinical manifestation of infection and current therapy. New York, N.Y: Academic Press; 1979. pp. 219–270. [Google Scholar]
  • 4.Fukuda H, Hosaka M, Hirai K, Iyobe S. New norfloxacin resistance gene in Pseudomonas aeruginosa PAO. Antimicrob Agents Chemother. 1990;34:1757–1761. doi: 10.1128/aac.34.9.1757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Hirai K, Suzue S, Irikura T, Iyobe S, Mitsuhashi S. Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1987;31:582–586. doi: 10.1128/aac.31.4.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Köhler T, Michéa-Hamzehpour M, Henze V, Gotoh N, Curty L K, Pechére J-C. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol. 1997;23:345–354. doi: 10.1046/j.1365-2958.1997.2281594.x. [DOI] [PubMed] [Google Scholar]
  • 7.Livermore D M, Davy K W M. Invalidity for Pseudomonas aeruginosa of an accepted model of bacterial permeability to β-lactam antibiotics. Antimicrob Agents Chemother. 1991;35:916–921. doi: 10.1128/aac.35.5.916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lei Y, Sato K, Nakae T. Ofloxacin-resistant Pseudomonas aeruginosa mutants with elevated drug extrusion across the inner membrane. Biochem Biophys Res Commun. 1991;178:1043–1048. doi: 10.1016/0006-291x(91)90997-l. [DOI] [PubMed] [Google Scholar]
  • 9.Masuda N, Gotoh N, Ishii C, Sakagawa E, Nishino T. Interplay between chromosomal β-lactamase and the MexAB-OprM efflux system in intrinsic resistance to β-lactams in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1999;43:400–402. doi: 10.1128/aac.43.2.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Morshed S R, Lei Y, Yoneyama H, Nakae T. Expression of genes associated with antibiotic extrusion in Pseudomonas aeruginosa. Biochem Biophys Res Commun. 1995;210:356–362. doi: 10.1006/bbrc.1995.1669. [DOI] [PubMed] [Google Scholar]
  • 11.Nikaido H. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob Agents Chemother. 1989;33:1831–1836. doi: 10.1128/aac.33.11.1831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Poole K, Gotoh N, Tsujimoto H, Zhao Q, Wada A, Yamasaki T, Neshat S, Yamagishi J, Li X-Z, Nishino T. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug resistant strain of Pseudomonas aeruginosa. Mol Microbiol. 1996;21:713–724. doi: 10.1046/j.1365-2958.1996.281397.x. [DOI] [PubMed] [Google Scholar]
  • 13.Poole K, Krebes K, McNally C, Neshat S. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol. 1993;175:7363–7372. doi: 10.1128/jb.175.22.7363-7372.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Poole K, Heinrichs D E, Neshat S. Cloning and sequence analysis of an EnvCD homologue in Pseudomonas aeruginosa: regulation by iron and possible involvement in the secretion of the siderophore pyoverdin. Mol Microbiol. 1993;10:529–544. doi: 10.1111/j.1365-2958.1993.tb00925.x. [DOI] [PubMed] [Google Scholar]
  • 15.Rella M, Haas D. Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of β-lactam antibiotics: mapping of chromosomal genes. Antimicrob Agents Chemother. 1982;22:242–249. doi: 10.1128/aac.22.2.242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sambrook J, Fritsch E F, Maniatis T. Molecular cloning: laboratory manual. 2nd ed. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory Press; 1989. [Google Scholar]
  • 17.Satake S, Yoneyama H, Nakae T. Role of OmpD2 and chromosomal β-lactamase in carbapenem resistance in clinical isolates of Pseudomonas aeruginosa. J Antimicrob Chemother. 1991;28:199–207. doi: 10.1093/jac/28.2.199. [DOI] [PubMed] [Google Scholar]
  • 18.Yoneyama H, Ocaktan A, Tsuda M, Nakae T. The role of mex gene products in antibiotic extrusion in Pseudomonas aeruginosa. Biochem Biophys Res Commun. 1997;233:611–618. doi: 10.1006/bbrc.1997.6506. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES